SANA

NASD Sana Biotechnology, Inc.
Oct 21, 2026 · 12:49 AM ET EOD Market Closed

$2.36 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.36, $0.06 below the day’s high of $2.42

YTD change
-42.01%
vs 20-day SMA
-14.47%
vs 200-day SMA
-32.27%

Price ranges

Previous day
$2.22 $2.36
open $2.32 close $2.30
-$0.02 (-0.86%)
Today
$2.25 $2.42
open $2.27 now $2.36
+$0.09 (+3.96%)
Past week
$2.22 $2.63
from $2.62 now $2.36
-$0.26 (-9.92%)
Past month
$2.22 $3.36
from $3.10 now $2.36
-$0.74 (-23.87%)
This year
$2.22 $5.20
from $4.07 now $2.36
-$1.71 (-42.01%)

Price & Performance

-1.46 (-38.22%) / 6M

$2.12$2.85$3.58$4.31Apr 20Jul 21Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 94.7% away from all-time highs of $44.60
  • SANA is down 42% since the beginning of the year
  • SANA is down 58% over the past 12 months
  • SANA is down 24% over the past 1 month
  • 20% of all SANA investors are betting against SANA

SANA reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -57.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.22
Earnings momentum -48.9% Quarterly EPS growth
Quarterly change -48.9%

Valuation

P/E ratio N/A
Enterprise value $589.1M
Beta 3.99

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$164.7M
Debt$73.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $706.5M

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $438.94 +3.29%
MRNA Moderna, Inc. $242.08 +6.69%
RVMD Revolution Medicines, Inc. $196.55 +7.91%
ROIV Roivant Sciences Ltd. $34.92 +0.63%
BNTX BioNTech SE Sponsored ADR $91.17 +2.20%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.